SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

The past 18 months has presented the generics and brand pharmaceutical industries with a dilemma unique to the US market: whether a partnership to launch and market a generic version of the brand ...

Citing the reason behind its observation, the credit rating firm in its report said that despite India exporting over half of ...

India has offered to supply complex generics at just 20–25 percent of the branded drug prices for the first three years after ...

Teva outlines its accelerated growth strategy focused on innovation, aiming for $5 billion in biopharma revenue by 2030, ...

Using generics results in more robust code and avoids ClassCastExceptions in your Java programs. This in-depth tutorial introduces you to generics and their types and methods. Generics are used in ...

The global branded generics market is forecasted to expand from USD 382.4 billion in 2025 to USD 860.5 billion by 2035, registering a CAGR of 8.4%. This growth is driven by rising healthcare ...

India's generics medicine industry is unlikely to be impacted by President Donald Trump's move to slash drug prices in the US drastically, said Sudarshan Jain, Secretary General, Indian Pharmaceutical ...

Plus, it is necessary to take into account price pressures, regulatory changes and increasing competition from generics and other big pharma. But in general, the company's approach looks adequate ...

These products were called “generics,” and if out-of-control costs were the problem, they were the solution. Well, sort of. The peas were starchy; the corn was bland. Generics weren’t awful ...

The share of generics in the Russian pharmaceutical market is steadily growing despite the efforts of the local state to ...